Martin Lagerblad

Board Director

Director

Insider activity · 24 months1 buy4 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 2 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 1 saleSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 1 saleJan 26 · 0 buys · 0 salesFeb 26 · 1 buy · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€277k

▼ Sales (3 ops.)

€127.3M

Latest filing published 12 Feb 2026 for Asker Healthcare Group AB (publ), €277k. Read the official filing

Filing timeline

BuySale

Martin Lagerblad

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

100%

T+90 mean return

+22.4%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Martin Lagerblad: trading record in brief

This profile gathers the share dealings of Martin Lagerblad in Asker Healthcare Group AB (publ), where the filings describe the role as board member. The record holds 8 filings, for trades running from 26 March 2025 to 12 February 2026.

Both buying and selling appear: 1 purchase worth €277k, against 3 sales worth €127.3M. On balance, insiders were net sellers of €127.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and no sales.

The latest filing, published on 12 February 2026, reports an open-market purchase of €277k in Asker Healthcare Group AB (publ). The median gap between a trade and its publication by Finansinspektionen is 2 days. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.